GlaxoSmithKline logoMaking a difference every day - Sustainability in Environment, Helath and Safety Report 2003
Corporate Responsibility Report 2003Download this Report
  EHS Home
  About this Report
  Scope
  Executive Statements
  Framework
  Issues
  Performance
  Verification Statement
  Global Reporting Initiative Content Index
  Index
   

 

Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Accident
Air emissions
Air pollution
Animal testing
Audit
Awards
Biodiversity
Capital
Chairman of the Board
Chemical Oxygen Demand (COD)
Chief Executive Officer
Climate change
Contaminated land
Costs
Driver safety
Emissions
Employee health
Environment
Ergonomics
Exposure limits
Fines
Forum for the Future
Framework
Genetically modified organisms (GMO)
Global Reporting Initiative (GRI)
Global warming
Green chemistry
GlaxoSmithKline
Guidelines
Hazard
Hazard communication
Hazardous waste
Health and safety
Human immunodeficiency virus (HIV)
Illness
Injury
International Standards Organisation (ISO)
Landfill
Lost time
Management systems
Material safety data sheet (MSDS)
Mental illness
Natural resources
Notice of violation
Occupational hygiene
Operations and maintenance
Organisation
Ozone depletion
Penalties
Performance
Pharmaceuticals in the environment
Photochemical ozone creation potential (POCP)
Planning
Process safety
Product stewardship
Recycle
Report scope
Reward and recognition
Safety engineering
Social responsibility
Solvents
Stakeholders
Strategy
Superfund
Suppliers
Sustainability
Sustainable development
Targets
Vision
Volatile organic compounds (VOC)
Waste
Waste disposal
Wastewater
Water
Water pollution
 
Previous
Next